Cipla launches generic remdesivir for COVID-19 patients

The USFDA had issued an Emergency Use Authorization (EUA) to Gilead
Sciences Inc for emergency use of remdesivir for the treatment of
COVID-19 patients.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cipla-launches-generic-remdesivir-for-covid-19-patients/articleshow/76498277.cms

Comments

Popular posts from this blog

Biotecnika Times Newsletter 25.10.2021 Tata Innovation Fellowship 2021, NCCS PhD Admission

TIGS-CI Biological Sciences Research Assistant Recruitment, Apply Online